抗CD317 (C-terminal)抗体 | Anti-CD317 (C-terminal) antibody

• 特長
• 価格
• DATA IMAGES
• 製品情報
• APPLICATION
• PROPERTIES
• TARGET

特長

• 高品質の抗体です。
• 幅広い研究分野に関連する抗体を取り揃えています。
• 使用されたアプリケーションや動物種などの情報が充実しています。
• 多数の論文で使用実績がある信頼性の高い抗体です。

目次に戻る

価格

目次に戻る

DATA IMAGES

Western blot data of bonemarrow stromal antigen 2 (CD317) on various grade levels of breast cancer cells.

目次に戻る

製品情報

Host	Rabbit
Clonality	Polyclonal
Isotype	IgG
Application	WB, ICC/IF, IHC
Reactivity	Human, Mouse, Rat

目次に戻る

APPLICATION

Application Note

We recommend the following starting dilutions:
1:500 for WB
1:150 for IHC
Optimal working dilutions should be determined experimentally be the end user.

Calculated MW	20 kDa. ( Note )

目次に戻る

PROPERTIES

Form	Liquid
Buffer	Phosphate, pH7.2-7.4
Storage	Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. Protect from light.
Concentration	Batch dependent (Please refer to the vial label for the specific concentration.)
Antigen Species	Human
Immunogen	Synthetic peptide
Purification	Affinity purified using antigen.
Conjugation	Fluorescein isothiocyanate (FITC)
Note	For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

目次に戻る

TARGET

Synonyms	Bone Marrow Stromal Cell Antigen 2 , Cd317 , Tetherin , Bst2
Background	May be involved in the sorting of secreted proteins (By similarity). May be involved in pre-B-cell growth. Antiretroviral defense protein, that blocks release of retrovirus from the cell surface. Depleted unpon HIV-1 infection by viral VPU protein through 20S proteasome degradation. Depleted upon infection by human Kaposi's sarcoma-associated herpesvirus (KSHV) through ubiquitination and subsequent degradation. May play a role in B-cell activation in rheumatoid arthritis.
Database	・ Gene ID: 684 ・ UniProt: Q10589

目次に戻る